Redwood Park Advisors’s AbbVie ABBV Stock Holding History

Redwood Park Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48K	Buy	221 +2	+0.9%	+$444	0.03%	104
2025 Q4	$50K	Buy	219 +1	+0.5%	+$228	0.03%	100
2025 Q3	$50.4K	Buy	218 +2	+0.9%	+$407	0.03%	96
2025 Q2	$40.1K	Sell	216 -9	-4%	-$1.67K	0.03%	113
2025 Q1	$47.1K	Hold	225	–	–	0.04%	97
2024 Q4	$40K	Buy	+225	New	+$41.4K	0.03%	114

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redwood Park Advisors's ABBV Position: Q1 2026 in Review

Redwood Park Advisors increased its AbbVie (ABBV) stake by 0.91% in Q1 2026, buying an estimated $444 and bringing the position to 221 shares worth $48K. The position accounts for 0.03% of the portfolio, ranked #104.

Redwood Park Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $50.4K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Redwood Park Advisors held 221 shares of AbbVie worth $48K as of Q1 2026.
Redwood Park Advisors bought 2 AbbVie shares in Q1 2026, an estimated $444.
AbbVie made up 0.03% of Redwood Park Advisors's portfolio in Q1 2026, its #104 holding.
Redwood Park Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Redwood Park Advisors's AbbVie position peaked at $50.4K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Redwood Park Advisors's 13F filing for Q1 2026, filed 4 May 2026.